Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches - Wilke, Carlo; Pujol-Calderón, Fani; Barro, Christian; Stransky, Elke; Blennow, Kaj; Michalak, Zuzanna; Deuschle, Christian; Jeromin, Andreas; Zetterberg, Henrik; Schüle, Rebecca; Höglund, Kina; Kuhle, Jens; et al. (Clinical chemistry and laboratory medicine, 2019)
Keywords: Adult; Aged; Alzheimer Disease - blood; Alzheimer Disease - cerebrospinal fluid; Amyotrophic lateral sclerosis; amyotrophic lateral sclerosis (ALS); Amyotrophic Lateral Sclerosis - blood; Amyotrophic Lateral Sclerosis - cerebrospinal fluid; Annan klinisk medicin; Assaying; Biomarkers; Biomarkers - blood; Blood; Cerebrospinal fluid; cerebrospinal fluid (CSF); Clinical Laboratory Techniques - methods; Correlation analysis; Cytoskeleton; Damage; Dementia disorders; Disease Progression; Enzyme-linked immunosorbent assay; Female; Frontotemporal dementia; frontotemporal dementia (FTD); Frontotemporal Dementia - blood; Frontotemporal Dementia - cerebrospinal fluid; Humans; Huntington Disease - blood; Huntington Disease - cerebrospinal fluid; Intermediate Filaments; Male; Mathematical analysis; Middle Aged; Neurodegenerative diseases; Neurofilament Proteins - analysis; Neurofilament Proteins - blood; Neurofilament Proteins - cerebrospinal fluid; Neurological diseases; Other Clinical Medicine; phosphorylated neurofilament heavy chain (pNfH); Phosphorylation; Reliability analysis; Reproducibility of Results; Sensitivity; Sensitivity analysis; serum; Serum - metabolism; Serum levels; single molecule array (Simoa); frontotemporal dementia (FTD); phosphorylated neurofilament heavy chain (pNfH); cerebrospinal fluid (CSF); serum; amyotrophic lateral sclerosis (ALS); single molecule array (Simoa)